Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:603579'
s ROE % Range Over the Past 10 Years
Min: 6.28 Med: 12.75 Max: 54.32
Current: 7.05
During the past 13 years, Shanghai Rongtai Health Technology's highest ROE % was 54.32%. The lowest was 6.28%. And the median was 12.75%.
SHSE:603579's ROE % is ranked better than 54.82% of 819
companies
in the Travel & Leisure industry
Industry Median: 5.57
vs SHSE:603579: 7.05
Shanghai Rongtai Health Technology (SHSE:603579) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Shanghai Rongtai Health Technology ROE % Related Terms
Shanghai Rongtai Health Technology ROE % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Leisure subindustry, Shanghai Rongtai Health Technology's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Rongtai Health Technology ROE % vs Travel & Leisure Industry
For the Travel & Leisure industry and Consumer Cyclical sector, Shanghai Rongtai Health Technology's ROE % distribution charts can be found below:
* The bar in red indicates where Shanghai Rongtai Health Technology's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Shanghai Rongtai Health Technology (SHSE:603579) has a ROE % of 9.87% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shanghai Rongtai Health Technology and its competitors. This is 23% below median its historical median of 12.75. Over the past decade, Shanghai Rongtai Health Technology's ROE % has ranged from 6.28 to 54.32. According to the industry distribution chart, Shanghai Rongtai Health Technology ranks #370 out of 819 companies in the Travel & Leisure industry, placing it in the top 45.2%.
Is Shanghai Rongtai Health Technology's ROE % too high?
Shanghai Rongtai Health Technology's current ROE % of 9.87% is 23% below median its 10-year median of 12.75. Over the past 10 years, this metric has ranged from a low of 6.28 to a high of 54.32. The Travel & Leisure industry median ROE % is 5.57. Shanghai Rongtai Health Technology's value of 9.87% is 77.2% above this industry median. Based on the distribution chart, Shanghai Rongtai Health Technology ranks #370 out of 819 companies in the Travel & Leisure industry, which is above the industry midpoint. Overall, Shanghai Rongtai Health Technology has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Rongtai Health Technology's ROE % compare to AS and HAS?
According to the Travel & Leisure industry distribution chart, Shanghai Rongtai Health Technology ranks #370 out of 819 companies for ROE %. This puts Shanghai Rongtai Health Technology in the upper half of its industry. The industry median ROE % is 5.57. Shanghai Rongtai Health Technology's value of 9.87% is 77.2% above this benchmark. Historically, Shanghai Rongtai Health Technology's own ROE % has ranged from 6.28 to 54.32 over the past decade. While the company's 10-year median is 12.75 vs. the industry median of 5.57, Shanghai Rongtai Health Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Travel & Leisure company?
The median ROE % among Travel & Leisure companies is 5.57, based on 819 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Rongtai Health Technology's current ROE % of 9.87% is 77.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Shanghai Rongtai Health Technology and its competitors. For the Travel & Leisure industry, the median ROE % is 5.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Rongtai Health Technology's current ROE % is 9.87%, which is 23% below median its own 10-year median of 12.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Rongtai Health Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology (SHSE:603579) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.92, compared to a current price of ¥16.30 — trading 2.4% above its estimated fair value. The current ROE % is 9.87%, which is 23% below median its 10-year median of 12.75 and 77.2% above the Travel & Leisure industry median of 5.57. Shanghai Rongtai Health Technology's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Shanghai Rongtai Health Technology (SHSE:603579), the current ROE % is 9.87% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Rongtai Health Technology (SHSE:603579) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Rongtai Health Technology stock appears to be overvalued.
The current stock price of ¥16.30 is trading 2.4% above its estimated GF Value™ of ¥15.92.
GuruFocus considers Shanghai Rongtai Health Technology to be Fairly Valued.
Key valuation signals for SHSE:603579:
ROE %: 9.87% (23% below median its 10-year median of 12.75)
GF Value™: ¥15.92 vs. price of ¥16.30 (2.4% above fair value)
Industry Position: 77.2% above the Travel & Leisure median (#370 of 819)
No single metric tells the full story. See the SHSE:603579 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Rongtai Health Technology Business Description
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
68GF Score
Get the complete analysis for SHSE:603579
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603579 has been successfully added to your 
